Atossa Therapeutics Inc ATOS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/18/21 EDT
5.30quote price arrow down-0.05 (-0.93%)
Volume
693,674
Close
5.35quote price arrow up+0.21 (+4.09%)
Volume
15,671,287
52 week range
0.81 - 6.82

...

Loading . . .
  • Open5.13
  • Day High5.55
  • Day Low5.02
  • Prev Close5.14
  • 52 Week High6.82
  • 52 Week High Date06/08/21
  • 52 Week Low0.81
  • 52 Week Low Date12/17/20

Key Stats

  • Market Cap646.39M
  • Shares Out120.82M
  • 10 Day Average Volume27.11M
  • Dividend-
  • Dividend Yield-
  • Beta2.15
  • YTD % Change463.16

KEY STATS

  • Open5.13
  • Day High5.55
  • Day Low5.02
  • Prev Close5.14
  • 52 Week High6.82
  • 52 Week High Date06/08/21
  • 52 Week Low0.81
  • 52 Week Low Date12/17/20
  • Market Cap646.39M
  • Shares Out120.82M
  • 10 Day Average Volume27.11M
  • Dividend-
  • Dividend Yield-
  • Beta2.15
  • YTD % Change463.16

RATIOS/PROFITABILITY

  • EPS (TTM)-1.52
  • P/E (TTM)-3.51
  • Fwd P/E (NTM)-34.52
  • EBITDA (MRQ)-15.158M
  • ROE (MRQ)-30.70%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/11/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Atossa Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Atossa Therapeutics Inc., formerly Atossa Genetics Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics and delivery methods for breast cancer and other breast conditions. Its pipeline includes two programs: endoxifen and intraductal microcatheter technology. It is developing Topical Endoxifen formulation for transdermal delivery. It is developing Topical Endoxifen to address two populations: to reduce mammographic breast...
Steven Quay M.D. Ph.D.
Chairman
Kyle Guse Esq. J.D.
Chief Financial Officer
Address
107 Spring St
Seattle, WA
98104-1005
United States

Top Peers

SYMBOLLASTCHG%CHG
TMDX
Transmedics Group Inc
29.78-0.20-0.67%
MLSS
Milestone Scientific Inc
1.93-0.02-1.03%
SINT
SINTX Technologies Inc
1.58+0.04+2.60%
BMRA
Biomerica Inc
3.97+0.10+2.58%
ULUR
ULURU Inc
0.5199UNCHUNCH